Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort

  1. Alonso, S.
  2. Riveiro-Barciela, M.
  3. Fernandez, I.
  4. Rincón, D.
  5. Real, Y.
  6. Llerena, S.
  7. Gea, F.
  8. Olveira, A.
  9. Fernandez-Carrillo, C.
  10. Polo, B.
  11. Carrión, J.A.
  12. Gómez, A.
  13. Devesa, M.J.
  14. Baliellas, C.
  15. Castro, Á.
  16. Ampuero, J.
  17. Granados, R.
  18. Pascasio, J.M.
  19. Rubín, A.
  20. Salmeron, J.
  21. Badia, E.
  22. Planas, J.M.M.
  23. Lens, S.
  24. Turnes, J.
  25. Montero, J.L.
  26. Buti, M.
  27. Esteban, R.
  28. Fernández-Rodríguez, C.M.
  29. Show all authors +
Journal:
Journal of Viral Hepatitis

ISSN: 1365-2893 1352-0504

Year of publication: 2017

Volume: 24

Issue: 4

Pages: 304-311

Type: Article

DOI: 10.1111/JVH.12648 GOOGLE SCHOLAR

Sustainable development goals